“Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35),” (PA-20-162, a reissue of PA-18-404, National Institute on Aging, in conjunction with other agencies, application deadline Jan. 25, May 25, and Sept. 25).
grants.nih.gov/grants/guide/pa-files/PA-20-162.html
“Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 – Clinical Trial Not Allowed),” (PAR-20-164, a reissue of PAR-17-234, National Institute on Aging, in conjunction with other agencies, application deadlines July 14, 2020, July 14, 2021, July 14, 2022).
“Lifespan Respite Care Program: State Program Enhancement Grants,” (HHS-2020-ACL-AOA-LRLI-0413, application deadline May 26, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=324184
A. “Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease (R01 Clinical Trial Optional),” (PAR-20-156, a reissue of PAR-17-032, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).
grants.nih.gov/grants/guide/pa-files/PAR-20-156.html
B. “Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R01 Clinical Trial Optional),” (PAR-20-157, a reissue of RFA-MH-19-510, National Institute of Mental Health, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R21 Clinical Trial Optional),” (PAR-20-159).
“Strengthening Aging Services for Minority Populations Through Technical Assistance, Resource Development, and Program Coordination,” (HHS-2020-ACL-AOA-HDRC-0411, application deadline May 29, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=324181
“Alzheimer’s Disease Programs Initiative – Dementia Capability in Indian Country,” (HHS-2020-ACL-AOA-ADPI-0418, application deadline May 26, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=324338
“Engaging Older Adults,” (HHS-2020-ACL-AOA-EECC-0414, application deadline May 29, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=324225
A. “Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32),” (PA-20-142, a reissue of of PA-18-403, National Institute on Aging, in conjunction with other agencies, application deadlines Jan. 25, May 25, and Sept. 25).
grants.nih.gov/grants/guide/pa-files/PA-20-142.html
B. “Firearm Injury and Mortality Prevention Research (R61 Clinical Trial Optional),” (PAR-20-143, National Institute on Aging, in conjunction with other agencies, application deadline May 15, 2020).
A. “Lifespan Respite Care Program: Technical Assistance and Resource Center,” (HHS-2020-ACL-AOA-LRLT-0412, application deadline May 12, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=324196
B. “Expanding the National Capacity for Person-Centered, Trauma-Informed (PCTI) Care: Services and Supports for Holocaust Survivors and Other Older Adults with a History of Trauma and Their Family Caregivers,” (HHS-2020-ACL-AOA-HSSG-0417, application deadline May 20, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=324337
“Disability and Rehabilitation Research Projects (DRRP) Program: Real Time Pressure Mapping to Reduce Risk of Pressure Ulcers,” (HHS-2020-ACL-NIDILRR-DPHF-0396, application deadline May 11, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=323556
“National Ombudsman Resource Center,” (HHS-2020-ACL-AOA-OMRC-0397, application deadline May 8, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=323622
“Alzheimer’s Disease Programs Initiative – Grants to States and Communities,” (HHS-2020-ACL-AOA-ADPI-0379, application deadline April 22, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=323189
A. “Prodromal {alpha}-Synucleinopathies Consortium (P{alpha}SS) (U19 Clinical Trial Optional),” (RFA-AG-21-013, National Institute on Aging, in conjunction with other agenices, application deadline June 17, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-013.html
B. “Network for Identification, Evaluation, and Tracking of Older Persons with Superior Cognitive Performance for Their Chronological Age (U19 Clinical Trial Not Allowed),” (RFA-AG-21-015, National Institute on Aging, application deadline October 1, 2020).
“U.S. Administration on Aging National Resource Centers on Older Indians, Alaska Natives and Native Hawaii Programs,” (HHS-2020-ACL-AOA-OIRC-0380, application deadline April 3, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=323210
A. “Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed),” (PAR-20-098, National Institute on Aging, in conjunction with other agencies, application deadlines Sept. 5, Jan. 5, and April 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed),” (PAR-20-109).
grants.nih.gov/grants/guide/pa-files/PAR-20-098.html
B. “Centers for AIDS Research (P30 Clinical Trial Not Allowed),” (PAR-20-106, a reissue of PAR-17-237, National Institute on Aging, in conjunction with other agencies, application deadlines July 28, 2020; July 28, 2021; July 28, 2022).
grants.nih.gov/grants/guide/pa-files/PAR-20-106.html
C. “Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed),” (PAR-20-107, a reissue of of PAR-17-238, National Institute on Aging, in conjunction with other agencies, application deadlines July 28, 2020; July 28, 2021; July 28, 2022).
grants.nih.gov/grants/guide/pa-files/PAR-20-107.html
D. “National Institute on Aging Genetics of Alzheimer’s Disease Data Storage Site (U24 Clinical Trial Not Allowed),” (PAR-20-110, a reissue of PAR-16-047, National Institute on Aging, application deadline Jan. 25, May 25, and Sept. 25).
A. “Resource Networks for Protein Polymorphisms in Alzheimer’s Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed),” (RFA-AG-21-012, National Institute on Aging, application deadline June 17, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-012.html
B. “National Alzheimer’s Coordinating Center (U24 Clinical Trial Not Allowed),” (RFA-AG-21-014, National Institute on Aging, application deadline June 17, 2020).
A. “Harmonization of Alzheimer’s Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed),” (PAR-20-099, National Institute on Aging, application deadlines Jan. 25, May 25, and Sept. 25).
grants.nih.gov/grants/guide/pa-files/PAR-20-099.html
B. “HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional),” (RFA-AT-20-004, a reissue of RFA-AT-19-004, National Institute on Aging, in conjunction with other agencies, application deadline March 30, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AT-20-004.html
C. “Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers (Collaborative U01 Clinical Trial Required),” (RFA-DK-20-501, a reissue of RFA-DK-15-503, National Institute on Aging, in conjunction with other agencies, application deadline April 22, 2020). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (BRC) (Collaborative U01 Clinical Trial Required),” (RFA-DK-20-502).
A. “Development of Research Education Resources for Geriatrics-Related Translational and Clinical Scientists (R25 Independent Clinical Trial Not Allowed),” (PAR-20-095, National Institute on Aging, application deadlines
grants.nih.gov/grants/guide/pa-files/PAR-20-095.html
B. “New/Unconventional Animal Models of Alzheimer’s Disease (R24 Clinical Trial Not Allowed),” (RFA-AG-21-003, National Institute on Aging, application deadline October 7, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-003.html
C. “Limited Competition: National Centralized Repository for Alzheimer’s Disease and Related Dementias (NCRAD) (U24 Clinical Trial Not Allowed),” (RFA-AG-21-005, a reissue of PAR-15-316, National Institute on Aging, application deadline June 17, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-005.html
D. “Central and Peripheral Control of Balance in Older Adults (R01 Clinical Trial Optional),” (RFA-AG-21-011, National Institute on Aging, in conjunction with other agencies, application deadline October 2, 2020).
A. “Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed),” (PAR-20-055, a reissue of of PAR-16-398, National Institute on Aging, in conjunction with other agenices, application deadlines Feb. 5, June, 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed),” (PAR-20-082).
grants.nih.gov/grants/guide/pa-files/PAR-20-055.html
B. “BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional),” (RFA-NS-20-006, a reissue of RFA-NS-18-018, National Institute on Aging, in conjunction with other agenices, application deadlines March 24, 2020, June 2, 2020, October 1, 2020, February 2, 2021, June 1, 2021, October 1, 2021, February 1, 2022, June 1, 2022, and October 3, 2022).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-006.html
C. “White Matter Lesion Etiology of Dementia in the U.S. Including in Health Disparity Populations (U19 Clinical Trial not Allowed),” (RFA-NS-20-013, National Institute on Aging, in conjunction with other agenices, application deadlines, March 31, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-013.html
D. “Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed),” (PAR-20-055, a reissue of PAR-16-398, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed),” (PAR-20-082).
“Steven H. Sandell Grant Program,” (application deadline for the 2020 program is January 31, 2020).
crr.bc.edu/about-us/grant-programs/steven-h-sandell-grant-program-2/
A. “Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed),” (RFA-AG-21-002, National Institute on Aging, application deadline June 17, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-002.html
B. “Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed),” (RFA-AG-21-010, National Institute on Aging, application deadline June 17, 2020).
A. “Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 – Clinical Trial Optional),” (PAR-20-070, a reissue of PAR-18-645, National Institute on Aging, application deadlines Feb. 16, June 16, and Oct. 16). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional),” (PAR-20-071).
grants.nih.gov/grants/guide/pa-files/PAR-20-070.html
B. “Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed),” (PAR-20-076, a reissue of PAR-17-096, National Institute on Aging, in conjunction with other agencies, application deadlines May 26, 2020; May 25, 2021; May 25, 2022).
grants.nih.gov/grants/guide/pa-files/PAR-20-076.html
C. “Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed),” (RFA-OD-20-005, a reissue of RFA-OD-19-016, National Institute on Aging, in conjunction with other agencies, application deadlines February 14, 2020, November 3, 2020, November 3, 2021). Note: There are four companion funding announcements (follow the link under “Companion Funding Opportunity”): “Small Research Grants for Analyses of Down Syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed),” (RFA-OD-20-006); “Development of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project Data Coordinating Center (U2C Clinical Trial Not Allowed),” (RFA-OD-20-007); “INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed),” (RFA-OD-20-004); and, “Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required),” (RFA-OD-20-003).
“Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed),” (PAR-20-076, a reissue of PAR-17-096, National Institute on Aging, in conjuction with other agencies, application deadlines May 26, 2020; May 25, 2021; May 25, 2022).
“Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 – Clinical Trial Optional),” (PAR-20-070, a reissue of PAR-18-645, National Institute on Aging, application deadlines Feb. 16, June 16, and Oct. 16). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional),” (PAR-20-071).
A. “NIA Research Centers Collaborative Network (RCCN) (U24 Clinical Trial Optional),” (RFA-AG-21-001, a reissue of RFA-AG-18-001, National Institute on Aging, application deadline May 15, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-001.html
B. “Emotional Well-Being: High-Priority Research Networks (U24, Clinical Trial Optional),” (RFA-AT-20-003, National Institute on Aging, in conjunction with other agencies, application deadline April 22, 2020).
A. “Improving Quality of Care and Patient Outcomes During Care Transitions (R01),” (PA-20-068, Agency for Healthcare Research and Quality, application deadlines Feb. 5, June 5, and Oct. 5).
grants.nih.gov/grants/guide/pa-files/PA-20-068.html
B. “AHRQ Mentored Research Scientist Career Development Award (K01),” (PA-20-067, a reissue of PA-16-223, Agency for Healthcare Research and Quality, application deadlines Feb. 12, June 12, and Oct. 12).
“2020 Empowering Communities to Reduce Falls and Falls Risk,” (HHS-2020-ACL-AOA-FPSG-0372, application deadline January 31, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=322423
A. “Clinical Trials Planning for Symptomatic Vascular Contributions to Cognitive Impairment and Dementia (VCID) (R34 Clinical Trial Not Allowed),” (RFA-NS-20-012, National Institute on Aging, in conjunction with other agenices, application receipt date March 31, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-012.html
B. “NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP-ENDURE) (R25 Clinical Trial Not Allowed),” (RFA-NS-20-015, National Institute on Aging, in conjunction with other agencies, application receipt date February 19, 2020).
“Disaster Assistance for State Units on Aging (SUAs) and Tribal Organizations in Major Disasters Declared by the President,” (HHS-2020-ACL-AOA-DASG-0364, application deadline September 7, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=322431
A. “Impact of Alcohol on the Onset and Progression of Alzheimer’s Disease and Its Related Dementias (R01 – Clinical Trial Optional),” (RFA-AA-20-006, National Institute on Aging, in conjunction with other agencies, application deadline March 24, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AA-20-006.html
B. “BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed),” (RFA-NS-19-043, National Institute on Aging, in conjunction with other agencies, application deadlines New February 10, 2020, June 10, 2020, October 9, 2020; February 10, 2021; June 9, 2021; October 6, 2021; February 10, 2022; June 8, 2022; October 11, 2022 Resubmission March 10, 2020, July 10, 2020, November 10, 2020; March 10, 2021; July 8, 2021; November 08, 2021; March 10, 2022; July 8, 2022; November 11, 2022). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required),” (RFA-NS-19-044).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-043.html
A. “2020 Integrated Networks to Deliver and Sustain Evidence-Based Falls Prevention Programs,” (HHS-2020-ACL-AOA-FPSG-0367, application deadline January 31, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=322351
B. “2020 Integrated Networks to Deliver and Sustain Evidence-Based Chronic Disease Self-Management Education Programs,” (HHS-2020-ACL-AOA-CSSG-0366, application deadline January 29, 2020).
C. “2020 Empowering Communities to Address Behavioral Health and Chronic Pain through Chronic Disease Self-Management Education Programs,” (HHS-2020-ACL-AOA-CSSG-0365, application deadline January 29, 2020).
“Leadership Award for Alzheimer’s Disease and Related Dementias Research (R35 Clinical Trial Not Allowed),” (RFA-AG-21-007, National Institute on Aging, application due data June 19, 2020).
A. “Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not Allowed),” (RFA-AG-20-027, National Institute on Aging, application deadline February 3, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-027.html
B. “A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimer’s Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trials Optional),” (RFA-AG-20-026, National Institute on Aging, application deadline February 3, 2020).
“Support of Competitive Research (SCORE) Research Advancement Award (SC1 – Clinical Trial Not Allowed),” (PAR-20-039, a reissue of PAR-16-439, National Institute on Aging, in conjunction with other agencies, application deadlines January 25, 2020; May 25, 2020; January 25, 2021; May 25, 2021; January 25, 2022; May 25, 2022). Note: There are two companion funding announcements associated with this announcement (follow the link under “Companion Funding Opportunity”): “Support of Competitive Research (SCORE) Pilot Project Award (SC2 – Clinical Trial Not Allowed),” (PAR-20-040); and, “Support of Competitive Research (SCORE) Research Continuance Award (SC3 – Clinical Trial Not Allowed),” (PAR-20-041).
“Aging Research Dissertation Awards to Increase Diversity (R36 Clinical Trial Not Allowed),” (PAR-19-394, a reissue of PAR-17-025, National Institute on Aging, application deadlines Feb. 16, June 16, and Oct. 16).
“Funding for 2020-2023 Older Americans Act Title VI Native American Programs,” (HHS-2020-ACL-TITLEVI-2001, application closing date December 18, 2019).
www.grants.gov/web/grants/view-opportunity.html?oppId=321645
“Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed),” (PAS-19-391, a reissue of RFA-AG-19-003, National Institute on Aging, application deadlines Feb. 16, June 16, and Oct. 16). Note: There are two companion funding announcements associated with this announcement (follow the link under “Companion Funding Opportunity”): “Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed),” (PAS-19-392); “Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed),” (PAS-19-393).
“Butler-Williams Scholars Program 2020,” (application deadline February 14, 2020).
A. “NIH Blueprint for Neuroscience Research Education Program on Translational Devices (R25 Clinical Trial Not Allowed),” (RFA-NS-20-003, National Institute on Aging, in conjunction with other agencies, application deadline December 16, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-003.html
B. “The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional),” (RFA-OD-19-029, National Institute on Aging, in conjunction with other agencies, applications deadlines November 25, 2019; November 25, 2020, November 26, 2021).
grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-029.html
C. “Low Cost Detection of Cognitive Decline in Clinical Settings (R01 Clinical Trial Required),” (RFA-AG-20-051, National Institute on Aging, application deadline January 30, 2020). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Low Cost Detection of Cognitive Decline in Clinical Settings (R61/R33 Clinical Trial Required),” (RFA-AG-20-050),
“Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed),” (PAR-19-373, National Institute on Aging, in conjunction with other agencies, applications deadlines March 17, 2020; March 17, 2021). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required),” (PAR-19-384).
A. “Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional),” (PAR-19-374, a reissue of PAR-18-296, National Institute on Aging, application deadlines Jan. 25, May 25, and Sept. 25).
grants.nih.gov/grants/guide/pa-files/PAR-19-374.html
B. “MD-PhD Training Program in Alzheimer’s Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed),” (RFA-AG-20-032, National Institute on Aging, application deadline October 28, 2019).
“Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed),” (PAR-19-372, a reissue of PAR-16-355, National Institute on Aging, in conjunction with other agencies, application deadlines November 6, 2019, November 6, 2020, November 8, 2021).
A. “Mechanistic Basis of TDP-43-dependent Pathobiology in Common Dementias (R01 Clinical Trial not Allowed),” (RFA-NS-20-005, National Institute on Aging, in conjunction with other agencies, application deadline November 15, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-005.html
B. “Peripheral Pathology in the Lewy Body Dementias (R01 Clinical Trial Not Allowed),” (RFA-NS-20-014, National Institute on Aging, in conjunction with other agencies, application deadline December 3, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-014.html
C. “Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Clinical Research Centers (U01 Clinical Trial Optional),” (RFA-DK-19-015, a reissue of RFA-DK-14-004, National Institute on Aging, in conjunction with other agencies, application deadline November 7, 2019).
“Limited Competition: Renewals of, and Revisions and Re-submissions to, the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed),” (PAR-19-338, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).
A. “Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed),” (PAR-19-338, National Institute on Aging, applications deadlines March 5, June 5, and Nov. 5).
grants.nih.gov/grants/guide/pa-files/PAR-19-338.html
B. “The Biological Mechanisms of Metformin Effects on Aging and Longevity (R01 Clinical Trial Not Allowed),” (RFA-AG-20-044, National Institute on Aging, application deadline January 21, 2020).
“SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed,” (PAR-19-333, a reissue of PAR-16-027, National Institute on Aging, in conjunction with other agencies, application deadlines Sept. 5, Jan. 5, and April 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed,” (PAR-19-334).
“Building Resources for the Basic Biology of Aging in Health Disparities Research (R24 Clinical Trial Not Allowed),” (RFA-AG-20-035, National Institute on Aging, application deadlines October 18, 2019 and October 19, 2020).
“Palliative Care in Home and Community Settings (R01 Clinical Trial Optional),” (PAR-19-321, National Institute of Nursing Research, application deadlines Oct. 5, Feb. 5, and June 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Palliative Care in Home and Community Settings (R21 Clinical Trial Optional),” (PAR-19-320).
A. “Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed),” (RFA-AG-20-010, a reissue of RFA-AG-19-017, National Institute on Aging, application deadline Oct. 22, 2019). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required),” (RFA-AG-20-011).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-010.html
B. “Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed),” (RFA-AG-20-030, National Institute on Aging, application deadline October 30, 2019).
“Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional),” (PAS-19-316, a reissue of PAS-18-187, National Institute on Aging, application deadlines Sept. 5, Jan. 5, and April 5). Note: Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional),” (PAS-19-317).
Powered by WordPress
